Quick Answer
LENZ Therapeutics, Inc. reported Shares Outstanding of 31.34 million shares for fiscal year 2025.
LENZ Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 31.34M | +13.9% |
| 2024 | 27.52M | +1297.3% |
| 2023 | 1.97M | -96.6% |
| 2022 | 58.22M | +0.4% |
| 2021 | 58.01M | +464.4% |
| 2020 | 10.28M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 28.59M | +4.0% | +0.3% |
| June 30, 2025 | 28.50M | +10.3% | +3.5% |
| March 31, 2025 | 27.54M | +8.0% | +0.1% |
| December 31, 2024 | 27.52M | +1297.3% | +0.1% |
| September 30, 2024 | 27.48M | -52.6% | +6.3% |
| June 30, 2024 | 25.85M | -55.4% | +1.4% |
| March 31, 2024 | 25.50M | -56.2% | +1194.8% |
| December 31, 2023 | 1.97M | -96.6% | -96.6% |
- LENZ Therapeutics, Inc. showed an increase of +13.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, LENZ Therapeutics, Inc.’s shares outstanding has grown by 204.9% (from 10.28 million shares to 31.34 million shares).
- The most recent figure is from LENZ Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: